SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-087877
Filing Date
2022-08-09
Accepted
2022-08-09 16:02:27
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20220630x10q.htm   iXBRL 10-Q 1435895
2 EXHIBIT-31.1 atxs-20220630xex31d1.htm EX-31.1 11400
3 EXHIBIT-31.2 atxs-20220630xex31d2.htm EX-31.2 11266
4 EXHIBIT-32.1 atxs-20220630xex32d1.htm EX-32.1 8452
  Complete submission text file 0001104659-22-087877.txt   5968746

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atxs-20220630.xsd EX-101.SCH 42673
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxs-20220630_cal.xml EX-101.CAL 43339
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxs-20220630_def.xml EX-101.DEF 187965
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20220630_lab.xml EX-101.LAB 382174
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20220630_pre.xml EX-101.PRE 291605
58 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20220630x10q_htm.xml XML 1027318
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 221148092
SIC: 2834 Pharmaceutical Preparations